vs
Side-by-side financial comparison of Inogen Inc (INGN) and SMITH & NEPHEW PLC (SNN). Click either name above to swap in a different company.
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $68.6M | — | ||
| Q3 25 | $79.1M | — | ||
| Q2 25 | $79.2M | — | ||
| Q1 25 | $68.5M | — | ||
| Q4 24 | $66.3M | — | ||
| Q3 24 | $74.9M | — | ||
| Q2 24 | $74.4M | — | ||
| Q1 24 | $63.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-5.3M | — | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-5.6M | — | ||
| Q1 24 | $-14.6M | — |
| Q4 25 | 51.4% | — | ||
| Q3 25 | 52.2% | — | ||
| Q2 25 | 52.2% | — | ||
| Q1 25 | 53.1% | — | ||
| Q4 24 | 54.7% | — | ||
| Q3 24 | 55.2% | — | ||
| Q2 24 | 57.4% | — | ||
| Q1 24 | 54.5% | — |
| Q4 25 | -13.6% | — | ||
| Q3 25 | -9.0% | — | ||
| Q2 25 | -7.7% | — | ||
| Q1 25 | -11.2% | — | ||
| Q4 24 | -17.2% | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -9.5% | — | ||
| Q1 24 | -25.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | -6.7% | — | ||
| Q2 25 | -5.2% | — | ||
| Q1 25 | -9.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -8.0% | — | ||
| Q2 24 | -7.5% | — | ||
| Q1 24 | -23.1% | — |
| Q4 25 | $-0.26 | — | ||
| Q3 25 | $-0.20 | — | ||
| Q2 25 | $-0.15 | — | ||
| Q1 25 | $-0.25 | — | ||
| Q4 24 | $-0.41 | — | ||
| Q3 24 | $-0.25 | — | ||
| Q2 24 | $-0.24 | — | ||
| Q1 24 | $-0.62 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
